Objective: To study factors that influence signs and symptoms related to stented ureter. Material & methods: This was a prospective-cross sectional study, from March 2014 to August 2014, to know factors that influence signs and symptoms of patients with ureteral stent. All patients were inserted ureteral stent participated in this study. Exclusion criteria were patients with malignancy, patients who had history of DJ stent placement previously, patients with bilateral DJ stents and patients with urinary tract infection. All patients completed IPSS questionnaire before inserted stents. After 1 month, when removal DJ stents performed, all patients completed IPSS, USSQ and VAS. All data was analyzed with Chi-square/fisher exact test, Pearson/Spearman correlation and Mann Whitney. Results: Fourty patients consisted of 23 man (57.5%) and 17 women (42.5%) completed this study. The mean age was 44.92 years old and length of stented ureter was 38.22 days. There was significance correlation between IPSS of DJ stent pre-insertion and post insertion (p < 0.001; r = 0.628). Of the patients reported dysuria (62.5%), frequency (55%), nocturia (52.5%), incomplete emptying (47.5%), hematuria (35%) and urgency (15%). On bivariate analysis, there was significance correlation between DJ stent position and frequency (p < 0.001), nocturia (< 0.001), urgency (p = 0.002), incomplete emptying (p = 0.049), dysuria (p = 0.030), hematuria (p = 0.026) and pain (p < 0.001). Conclusion: Previous urinary symptoms and DJ stent position were factors that influenced sign and symptoms related to ureteral stent insertion.
Stent, ureter, sign and symptom
Miyaoka R, Monga M. Ureteral stent discomfort: etiology and management. Indian J Urol. 2009; 25(4): 455-60.
Leibovici D, Cooper A, Lindner A, Ostrowsky R, Kleinnman J, Velikanov S, et al. Ureteral stent: morbidity and impact on quality of life. IMAJ. 2005; 7: 491-4.
Probzt CEM, Razvi H, Dendstedt J. Fundamentals of instrumentation and urinary tract drainage. In Wein, Kavaoussi, Novick, Partin, Peters, editors. Campbell Walsh Urology, 10th ed. 2012.
Lim JS, Sul CK, Song KH, Na YG, Shin JH, Oh TH, et al. Changes in urinary symptoms and tolerance due to long term ureteral double J stenting. Int J Urol. 2010; 14(2): 93-99.
Richter S, Ringel A, Shaley M, Nissenkom I. The indwelling ureteric stent: a friendly procedure with unfriendly high morbidity. BJU Int. 2000; 85: 408-11.
Pearle MS, Lotan Y. Urinary lithiasis: Pathology, epidemiology, and pathogenesis. In Wein, Kavaoussi, Novick, Partin, Peters, editors. Campbell Walsh Urology, 10th ed. 2012.
Joshi HB, Stainthorpe IA, Macdonagh RP, Keeley FX, Timoney AG. Indwelling ureteral stents: Evaluation of symptoms, quality of life and utility. J Urol. 2003; 3(169): 1065–9.
Joshi HB, Okeke A, Newns N, Keeley FX Jr, Timoney AG. Characterization of urinary symptoms in patients with ureteral stents. Urology. 2002; 59(4): 511-6.
Damiano R, Autorino R, De Sio M, Cantiello F, Quarto G, Perdona S, et al. Does the size of ureteral stent impact urinary symptoms and quality of life? A Prospective Randomized Study. Eur Urol. 2005; 48(4): 673-8.
Lee BK, Paick SH, Park HK, Kim HG, Lho YS. Is a 22 cm ureteric stent appropriate for Korean patients smaller than 175 cm in height? Korean J Urol. 2010; 51: 642-6.
Lee SJ, Yoo C, Oh CY, Lee YS, Cho ST, Lee SH, et al. Stent position is more important than α-blockers or anticholinergics for stent-related lower urinary tract symptoms after ureteroscopic ureterolithotomy: A Prospective Randomized Study. Korean J Urol. 2010; 51: 636-41.